Literature DB >> 28009552

Quantitative characterization of the X-ray beam at the Australian Synchrotron Imaging and Medical Beamline (IMBL).

Andrew W Stevenson1, Jeffrey C Crosbie2, Christopher J Hall1, Daniel Häusermann1, Jayde Livingstone1, Jessica E Lye2.   

Abstract

A critical early phase for any synchrotron beamline involves detailed testing, characterization and commissioning; this is especially true of a beamline as ambitious and complex as the Imaging & Medical Beamline (IMBL) at the Australian Synchrotron. IMBL staff and expert users have been performing precise experiments aimed at quantitative characterization of the primary polychromatic and monochromatic X-ray beams, with particular emphasis placed on the wiggler insertion devices (IDs), the primary-slit system and any in vacuo and ex vacuo filters. The findings from these studies will be described herein. These results will benefit IMBL and other users in the future, especially those for whom detailed knowledge of the X-ray beam spectrum (or `quality') and flux density is important. This information is critical for radiotherapy and radiobiology users, who ultimately need to know (to better than 5%) what X-ray dose or dose rate is being delivered to their samples. Various correction factors associated with ionization-chamber (IC) dosimetry have been accounted for, e.g. ion recombination, electron-loss effects. A new and innovative approach has been developed in this regard, which can provide confirmation of key parameter values such as the magnetic field in the wiggler and the effective thickness of key filters. IMBL commenced operation in December 2008 with an Advanced Photon Source (APS) wiggler as the (interim) ID. A superconducting multi-pole wiggler was installed and operational in January 2013. Results are obtained for both of these IDs and useful comparisons are made. A comprehensive model of the IMBL has been developed, embodied in a new computer program named spec.exe, which has been validated against a variety of experimental measurements. Having demonstrated the reliability and robustness of the model, it is then possible to use it in a practical and predictive manner. It is hoped that spec.exe will prove to be a useful resource for synchrotron science in general, and for hard X-ray beamlines, whether they are based on bending magnets or insertion devices, in particular. In due course, it is planned to make spec.exe freely available to other synchrotron scientists.

Entities:  

Keywords:  X-ray beam quality; dosimetry; ionization chambers

Mesh:

Year:  2017        PMID: 28009552     DOI: 10.1107/S1600577516015563

Source DB:  PubMed          Journal:  J Synchrotron Radiat        ISSN: 0909-0495            Impact factor:   2.616


  8 in total

1.  SyncMRT: a solution to image-guided synchrotron radiotherapy for quality assurance and pre-clinical trials.

Authors:  M J Barnes; J Paino; L R Day; D Butler; D Häusermann; D Pelliccia; J C Crosbie
Journal:  J Synchrotron Radiat       Date:  2022-06-07       Impact factor: 2.557

2.  Evaluation of silicon strip detectors in transmission mode for online beam monitoring in microbeam radiation therapy at the Australian Synchrotron.

Authors:  Jeremy Davis; Andrew Dipuglia; Matthew Cameron; Jason Paino; Ashley Cullen; Susanna Guatelli; Marco Petasecca; Anatoly Rosenfeld; Michael Lerch
Journal:  J Synchrotron Radiat       Date:  2022-01-01       Impact factor: 2.616

3.  Modification of the Langendorff system of the isolated beating heart for experimental radiotherapy at a synchrotron: 4000 Gy in a heart beat.

Authors:  Elisabeth Schültke; Michael Lerch; Timo Kirschstein; Falko Lange; Katrin Porath; Stefan Fiedler; Jeremy Davis; Jason Paino; Elette Engels; Micah Barnes; Mitzi Klein; Christopher Hall; Daniel Häusermann; Guido Hildebrandt
Journal:  J Synchrotron Radiat       Date:  2022-05-18       Impact factor: 2.557

4.  Double-multilayer monochromators for high-energy and large-field X-ray imaging applications with intense pink beams at SPring-8 BL20B2.

Authors:  Takahisa Koyama; Yasunori Senba; Hiroshi Yamazaki; Tomoyuki Takeuchi; Masayuki Tanaka; Yasuhiro Shimizu; Koji Tsubota; Yasuhisa Matsuzaki; Hikaru Kishimoto; Takanori Miura; Satsuki Shimizu; Takamitsu Saito; Hirokatsu Yumoto; Kentaro Uesugi; Masato Hoshino; Jumpei Yamada; Taito Osaka; Michihiro Sugahara; Nobuteru Nariyama; Yasuhide Ishizawa; Hiroko Nakano; Choji Saji; Kyo Nakajima; Koji Motomura; Yasumasa Joti; Makina Yabashi; Haruhiko Ohashi
Journal:  J Synchrotron Radiat       Date:  2022-07-15       Impact factor: 2.557

5.  X-ray microbeam measurements with a high resolution scintillator fibre-optic dosimeter.

Authors:  James Archer; Enbang Li; Marco Petasecca; Andrew Dipuglia; Matthew Cameron; Andrew Stevenson; Chris Hall; Daniel Hausermann; Anatoly Rosenfeld; Michael Lerch
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

6.  Toward personalized synchrotron microbeam radiation therapy.

Authors:  Elette Engels; Nan Li; Jeremy Davis; Jason Paino; Matthew Cameron; Andrew Dipuglia; Sarah Vogel; Michael Valceski; Abass Khochaiche; Alice O'Keefe; Micah Barnes; Ashley Cullen; Andrew Stevenson; Susanna Guatelli; Anatoly Rosenfeld; Michael Lerch; Stéphanie Corde; Moeava Tehei
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

7.  Methods for dynamic synchrotron X-ray respiratory imaging in live animals.

Authors:  Kaye Susannah Morgan; David Parsons; Patricia Cmielewski; Alexandra McCarron; Regine Gradl; Nigel Farrow; Karen Siu; Akihisa Takeuchi; Yoshio Suzuki; Kentaro Uesugi; Masayuki Uesugi; Naoto Yagi; Chris Hall; Mitzi Klein; Anton Maksimenko; Andrew Stevenson; Daniel Hausermann; Martin Dierolf; Franz Pfeiffer; Martin Donnelley
Journal:  J Synchrotron Radiat       Date:  2020-01-01       Impact factor: 2.616

8.  Synchrotron X-Ray Radiation-Induced Bystander Effect: An Impact of the Scattered Radiation, Distance From the Irradiated Site and p53 Cell Status.

Authors:  Pavel Lobachevsky; Helen B Forrester; Alesia Ivashkevich; Joel Mason; Andrew W Stevenson; Chris J Hall; Carl N Sprung; Valentin G Djonov; Olga A Martin
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.